Bartlett & Co. Wealth Management LLC Novartis Ag Transaction History

Bartlett & Co. Wealth Management LLC

  • $6.97 Trillion
  • Q3 2024

A detailed history of Bartlett & Co. Wealth Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 117,169 shares of NVS stock, worth $11.5 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
117,169
Previous 121,676 3.7%
Holding current value
$11.5 Million
Previous $13 Billion 4.04%
% of portfolio
0.19%
Previous 0.2%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
SELL
$106.13 - $120.89 $478,327 - $544,851
-4,507 Reduced 3.7%
117,169 $13.5 Billion
Q2 2024

Jul 12, 2024
SELL
$92.57 - $107.37 $1.61 Million - $1.87 Million
-17,402 Reduced 12.51%
121,676 $13 Billion
Q1 2024

May 09, 2024
SELL
$95.27 - $108.47 $1.14 Million - $1.3 Million
-11,968 Reduced 7.92%
139,078 $13.9 Billion
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $184,540 - $203,080
-2,000 Reduced 1.31%
151,046 $15.1 Billion
Q3 2023

Feb 14, 2024
SELL
$94.73 - $105.13 $257,855 - $286,163
-2,722 Reduced 1.75%
153,046 $15.6 Billion
Q2 2023

Feb 14, 2024
SELL
$92.52 - $104.91 $1.09 Million - $1.24 Million
-11,825 Reduced 7.06%
155,768 $15.7 Billion
Q1 2023

Feb 14, 2024
SELL
$80.03 - $92.81 $822,548 - $953,901
-10,278 Reduced 5.78%
167,593 $15.4 Billion
Q4 2022

Feb 14, 2024
SELL
$75.55 - $92.52 $256,416 - $314,012
-3,394 Reduced 1.87%
177,871 $16.1 Billion
Q3 2022

Feb 14, 2024
SELL
$74.61 - $87.26 $212,489 - $248,516
-2,848 Reduced 1.55%
181,265 $13.8 Billion
Q2 2022

Feb 14, 2024
SELL
$80.52 - $93.75 $2.52 Million - $2.94 Million
-31,329 Reduced 14.54%
184,113 $15.6 Billion
Q1 2022

Feb 14, 2024
SELL
$80.11 - $90.62 $43,499 - $49,206
-543 Reduced 0.25%
215,442 $18.9 Billion
Q4 2021

Feb 14, 2024
SELL
$79.7 - $88.13 $393,558 - $435,185
-4,938 Reduced 2.24%
215,985 $18.9 Billion
Q3 2021

Feb 13, 2024
SELL
$81.78 - $95.14 $90,775 - $105,605
-1,110 Reduced 0.5%
220,923 $18.1 Billion
Q2 2021

Feb 13, 2024
SELL
$85.24 - $94.15 $668,025 - $737,853
-7,837 Reduced 3.41%
222,033 $20.3 Billion
Q1 2021

Feb 13, 2024
SELL
$83.5 - $98.47 $570,472 - $672,747
-6,832 Reduced 2.89%
229,870 $19.7 Billion
Q4 2020

Feb 13, 2024
SELL
$78.07 - $94.43 $318,837 - $385,652
-4,084 Reduced 1.7%
236,702 $22.4 Billion
Q3 2020

Feb 13, 2024
BUY
$82.14 - $91.0 $510,500 - $565,565
6,215 Added 2.65%
240,786 $20.9 Billion
Q2 2020

Feb 13, 2024
SELL
$80.93 - $91.1 $250,235 - $281,681
-3,092 Reduced 1.3%
234,571 $20.5 Billion
Q1 2020

Feb 13, 2024
SELL
$70.67 - $99.01 $445,786 - $624,555
-6,308 Reduced 2.59%
237,663 $19.6 Billion
Q4 2019

Feb 13, 2024
SELL
$84.35 - $95.37 $294,297 - $332,745
-3,489 Reduced 1.41%
243,971 $23.1 Billion
Q3 2019

Feb 13, 2024
SELL
$85.54 - $94.26 $845,562 - $931,760
-9,885 Reduced 3.84%
247,460 $21.5 Billion
Q2 2019

Feb 13, 2024
SELL
$75.4 - $92.8 $14.4 Million - $17.7 Million
-190,834 Reduced 42.58%
257,345 $23.5 Billion
Q1 2019

Feb 13, 2024
SELL
$75.32 - $86.15 $236,580 - $270,597
-3,141 Reduced 0.7%
448,179 $43.1 Billion
Q4 2018

Feb 13, 2024
SELL
$73.66 - $82.02 $261,198 - $290,842
-3,546 Reduced 0.78%
451,320 $38.7 Billion
Q3 2018

Feb 13, 2024
SELL
$66.94 - $77.43 $87,624 - $101,355
-1,309 Reduced 0.29%
454,866 $39.2 Billion
Q2 2018

Feb 13, 2024
SELL
$64.91 - $73.36 $725,758 - $820,238
-11,181 Reduced 2.39%
456,175 $34.5 Billion
Q1 2018

Feb 13, 2024
BUY
$70.39 - $84.15 $32.9 Million - $39.3 Million
467,356 New
467,356 $37.8 Billion

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email